RA
CTSO icon

Royce & Associates’s Cytosorbents Corp CTSO Stock Holding History

Royce & Associates’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-349,000
Closed -$764K – 943
2022
Q2 		$764K Hold
349,000
– – 0.01% 790
2022
Q1 		$1.11M Buy
349,000
+98,000
+39% +$351K 0.01% 800
2021
Q4 		$1.05M Buy
251,000
+55,000
+28% +$309K 0.01% 799
2021
Q3 		$1.59M Buy
196,000
+59,000
+43% +$479K 0.01% 766
2021
Q2 		$1.03M Hold
137,000
– – 0.01% 847
2021
Q1 		$1.19M Hold
137,000
– – 0.01% 833
2020
Q4 		$1.09M Hold
137,000
– – 0.01% 804
2020
Q3 		$1.09M Buy
137,000
+20,000
+17% +$180K 0.01% 770
2020
Q2 		$1.16M Buy
117,000
+53,688
+85% +$493K 0.01% 755
2020
Q1 		$489K Buy
+63,312
New +$320K 0.01% 836

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return